Edmund J. Roschak
Directeur Général chez Vascular Dynamics, Inc.
Profil
Edmund J.
Roschak is currently the President, Chief Executive Officer & Director at Vascular Dynamics, Inc., Chairman at ApiFix Ltd., and Chairman at B2M Medical, Inc. He was previously the President, Chief Executive Officer & Director at Ellipse Technologies, Inc., Chief Executive Officer at NuVasive Specialized Orthopedics, Inc., Senior Product Development Engineer at HP, Inc., and Senior Vice President-Research & Development at Broncus Technologies, Inc. Roschak holds an undergraduate degree from the University of California, Santa Barbara and an MBA from the University of Oregon.
Postes actifs de Edmund J. Roschak
| Sociétés | Poste | Début |
|---|---|---|
Vascular Dynamics, Inc.
 Vascular Dynamics, Inc. Medical SpecialtiesHealth Technology Vascular Dynamics, Inc. provides blood pressure modulation devices. It develops and commercializes a passive, catheter-delivered implant for the treatment of hypertension. The company was founded in 2008 and is headquartered in Mountain View, CA. | Directeur Général | 04/12/2017 |
ApiFix Ltd.
 ApiFix Ltd. Medical SpecialtiesHealth Technology ApiFix Ltd. engages in the development of invasive scoliosis deformity correction systems for adolescent idiopathic scoliosis. The company was founded by Yizhar Floman and Uri Arnin in 2011 and is headquartered in Misgav, Israel. | Président | 01/12/2017 |
| B2M Medical, Inc. | Président | - |
Anciens postes connus de Edmund J. Roschak
| Sociétés | Poste | Fin |
|---|---|---|
NuVasive Specialized Orthopedics, Inc.
 NuVasive Specialized Orthopedics, Inc. Medical SpecialtiesHealth Technology Part of Globus Medical, Inc., NuVasive Specialized Orthopedics, Inc. develops and manufactures remote controlled implants. The company is based in San Diego, CA. | Directeur Général | 30/06/2017 |
Ellipse Technologies, Inc.
 Ellipse Technologies, Inc. Medical SpecialtiesHealth Technology Ellipse Technologies, Inc. develops and commercializes implants for spinal and orthopedic applications. It designs, develop and commercialize non-invasively adjustable, remote controlled implants for a broad spectrum of spinal and orthopedic applications. The company was founded by Samuel M. Shaolian and Shawn Moaddeb on June 30, 2005 and is headquartered in Aliso Viejo, CA. | Directeur Général | 01/02/2016 |
Broncus Technologies, Inc.
 Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients. | Directeur Technique/Scientifique/R&D | 01/02/2013 |
| HP INC. | Corporate Officer/Principal | 01/04/2000 |
Formation de Edmund J. Roschak
| University of California, Santa Barbara | Undergraduate Degree |
| University of Oregon | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HP INC. | Electronic Technology |
| Entreprise privées | 6 |
|---|---|
Broncus Technologies, Inc.
Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients. | Health Technology |
Ellipse Technologies, Inc.
Ellipse Technologies, Inc. Medical SpecialtiesHealth Technology Ellipse Technologies, Inc. develops and commercializes implants for spinal and orthopedic applications. It designs, develop and commercialize non-invasively adjustable, remote controlled implants for a broad spectrum of spinal and orthopedic applications. The company was founded by Samuel M. Shaolian and Shawn Moaddeb on June 30, 2005 and is headquartered in Aliso Viejo, CA. | Health Technology |
Vascular Dynamics, Inc.
Vascular Dynamics, Inc. Medical SpecialtiesHealth Technology Vascular Dynamics, Inc. provides blood pressure modulation devices. It develops and commercializes a passive, catheter-delivered implant for the treatment of hypertension. The company was founded in 2008 and is headquartered in Mountain View, CA. | Health Technology |
ApiFix Ltd.
ApiFix Ltd. Medical SpecialtiesHealth Technology ApiFix Ltd. engages in the development of invasive scoliosis deformity correction systems for adolescent idiopathic scoliosis. The company was founded by Yizhar Floman and Uri Arnin in 2011 and is headquartered in Misgav, Israel. | Health Technology |
NuVasive Specialized Orthopedics, Inc.
NuVasive Specialized Orthopedics, Inc. Medical SpecialtiesHealth Technology Part of Globus Medical, Inc., NuVasive Specialized Orthopedics, Inc. develops and manufactures remote controlled implants. The company is based in San Diego, CA. | Health Technology |
| B2M Medical, Inc. |